Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v1-EN
Language English English
Date Updated 2022-02-23 2021-12-28
Drug Identification Number 02353997 02353997
Brand name UROCIT-K UROCIT-K
Common or Proper name Potassium Citrate Extended Release Tablets Potassium Citrate Extended Release Tablets
Company Name MISSION PHARMACAL COMPANY MISSION PHARMACAL COMPANY
Ingredients POTASSIUM CITRATE POTASSIUM CITRATE
Strength(s) 1080MG 1080MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100-ct 100-ct
ATC code A12BA A12BA
ATC description POTASSIUM POTASSIUM
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2021-12-24 2021-12-24
Actual start date 2021-12-22 2021-12-24
Estimated end date 2022-02-15 2022-03-01
Actual end date 2022-02-22
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Delay from label supplier. Delay from label supplier.
Health Canada comments